Medpace
MEDP
231 hedge funds and large institutions have $1.64B invested in Medpace in 2019 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 83 increasing their positions, 74 reducing their positions, and 42 closing their positions.
38% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 42
12% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 74
7% more funds holding
Funds holding: 216 → 231 (+15)
5% more capital invested
Capital invested by funds: $1.56B → $1.64B (+$82.5M)
0% more call options, than puts
Call options by funds: $10.4M | Put options by funds: $10.3M
5.4% less ownership
Funds ownership: 83.44% → 78.04% (-5.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$17.4M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$12.5M |
| 4 |
Capital Fund Management (CFM)
Paris,
France
|
+$12M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$11.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$28.1M |
| 2 |
Bank of New York Mellon
New York
|
-$19.8M |
| 3 |
Two Sigma Advisers
New York
|
-$14.8M |
| 4 |
Renaissance Technologies
New York
|
-$14.7M |
| 5 |
Millennium Management
New York
|
-$14.1M |
MEDP Hedge Fund Activity: Q1 2019 in Review
231 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2019, worth a combined $1.64B — up 5.3% from $1.56B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new MEDP positions and 42 closed out — a net gain of 16 holders — while 83 added to existing stakes and 74 trimmed.
The largest buyer was Vanguard Group, adding an estimated $23.1M. The largest seller was Fuller & Thaler Asset Management, cutting an estimated $28.1M.
- 231 institutional investors held Medpace (MEDP) as of Q1 2019, up from 216 in Q4 2018.
- Funds reported $1.64B of Medpace stock for Q1 2019, up 5.3% quarter-over-quarter.
- 58 funds opened new Medpace positions in Q1 2019 and 42 closed out, a net change of +16 holders.
- The largest Medpace buyer in Q1 2019 was Vanguard Group, an estimated $23.1M added.
- The largest Medpace seller in Q1 2019 was Fuller & Thaler Asset Management, an estimated $28.1M sold.
Based on aggregated 13F filings for Q1 2019.